|
KIF20A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.962700E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.247300E-04 |
| Normal-vs-Stage2 |
1.428600E-01 |
| Normal-vs-Stage3 |
1.122480E-02 |
| Normal-vs-Stage4 |
1.718400E-03 |
| Stage1-vs-Stage2 |
9.696000E-02 |
| Stage1-vs-Stage3 |
9.064000E-01 |
| Stage1-vs-Stage4 |
3.850200E-01 |
| Stage2-vs-Stage3 |
1.712840E-01 |
| Stage2-vs-Stage4 |
4.750100E-02 |
| Stage3-vs-Stage4 |
6.096600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.242600E-04 |
| Normal-vs-AfricanAmerican |
1.212440E-01 |
| Normal-vs-Asian |
2.782500E-03 |
| Caucasian-vs-AfricanAmerican |
5.296200E-01 |
| Caucasian-vs-Asian |
8.811600E-01 |
| AfricanAmerican-vs-Asian |
4.548800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.830800E-04 |
| Normal-vs-Female |
2.019300E-03 |
| Male-vs-Female |
1.515170E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.577900E-04 |
| Normal-vs-Age(41-60Yrs) |
3.066200E-02 |
| Normal-vs-Age(61-80Yrs) |
7.217200E-03 |
| Normal-vs-Age(81-100Yrs) |
1.796620E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.444110E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.858800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.225800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.042390E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.360800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.889200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.042000E-01 |
| Classical-VS-Follicular |
2.704500E-03 |
| Classical-VS-Other |
3.850600E-01 |
| Classical-VS-Normal |
1.017500E-04 |
| Tall-VS-Follicular |
1.196590E-01 |
| Tall-VS-Other |
7.065000E-01 |
| Tall-VS-Normal |
1.504090E-02 |
| Follicular-VS-Other |
6.265800E-01 |
| Follicular-VS-Normal |
1.492240E-01 |
| Other-VS-Normal |
2.517400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.564200E-03 |
| Normal-vs-N1 |
6.098800E-03 |
| N0-vs-N1 |
8.395600E-01 |
|
|
